Department of Neurology and Neurosurgery, UMC Utrecht Brain Center (W.M.S., L.J.K., H.B.v.d.W., A.M.A.), University Medical Center Utrecht, Utrecht University, the Netherlands.
Department of Cardiology, Division of Heart and Lungs (M.L., F.W.A.), University Medical Center Utrecht, Utrecht University, the Netherlands.
Stroke. 2021 Dec;52(12):3978-3986. doi: 10.1161/STROKEAHA.121.034787. Epub 2021 Nov 4.
The frequency of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) varies in the current literature, and risk factors are unknown. We assessed the incidence, risk factors, and outcomes of acute ischemic stroke in hospitalized patients with COVID-19.
We included patients with a laboratory-confirmed SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) infection admitted in 16 Dutch hospitals participating in the international CAPACITY-COVID registry between March 1 and August 1, 2020. Patients were screened for the occurrence of acute ischemic stroke. We calculated the cumulative incidence of ischemic stroke and compared risk factors, cardiovascular complications, and in-hospital mortality in patients with and without ischemic stroke.
We included 2147 patients with COVID-19, of whom 586 (27.3%) needed treatment at an intensive care unit. Thirty-eight patients (1.8%) had an ischemic stroke. Patients with stroke were older but did not differ in sex or cardiovascular risk factors. Median time between the onset of COVID-19 symptoms and diagnosis of stroke was 2 weeks. The incidence of ischemic stroke was higher among patients who were treated at an intensive care unit (16/586; 2.7% versus nonintensive care unit, 22/1561; 1.4%; =0.039). Pulmonary embolism was more common in patients with (8/38; 21.1%) than in those without stroke (160/2109; 7.6%; adjusted risk ratio, 2.08 [95% CI, 1.52-2.84]). Twenty-seven patients with ischemic stroke (71.1%) died during admission or were functionally dependent at discharge. Patients with ischemic stroke were at a higher risk of in-hospital mortality (adjusted risk ratio, 1.56 [95% CI, 1.13-2.15]) than patients without stroke.
In this multicenter cohort study, the cumulative incidence of acute ischemic stroke in hospitalized patients with COVID-19 was ≈2%, with a higher risk in patients treated at an intensive care unit. The majority of stroke patients had a poor outcome. The association between ischemic stroke and pulmonary embolism warrants further investigation.
目前文献中报道的 2019 年冠状病毒病(COVID-19)患者中缺血性脑卒中的发生率各不相同,且风险因素尚不明确。我们评估了住院 COVID-19 患者中急性缺血性脑卒中的发生率、风险因素和结局。
我们纳入了 2020 年 3 月 1 日至 8 月 1 日期间在参与国际 CAPACITY-COVID 登记研究的 16 家荷兰医院住院、实验室确诊的严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染患者。对这些患者发生急性缺血性脑卒中的情况进行了筛查。我们计算了缺血性脑卒中的累积发生率,并比较了有和无缺血性脑卒中患者的风险因素、心血管并发症和院内死亡率。
我们共纳入了 2147 例 COVID-19 患者,其中 586 例(27.3%)需要在重症监护病房治疗。38 例(1.8%)患者发生了缺血性脑卒中。发生脑卒中的患者年龄较大,但在性别和心血管危险因素方面无差异。COVID-19 症状出现与脑卒中诊断之间的中位时间为 2 周。在重症监护病房治疗的患者中,缺血性脑卒中的发生率更高(16/586;2.7%,而非重症监护病房 22/1561;1.4%;=0.039)。与无脑卒中的患者(160/2109;7.6%)相比,有脑卒中的患者更常见肺栓塞(8/38;21.1%;调整风险比,2.08[95%CI,1.52-2.84])。27 例缺血性脑卒中患者(71.1%)在住院期间死亡或出院时存在功能依赖性。与无脑卒中的患者相比,有脑卒中的患者院内死亡率更高(调整风险比,1.56[95%CI,1.13-2.15])。
在这项多中心队列研究中,住院 COVID-19 患者中急性缺血性脑卒中的累积发生率约为 2%,在重症监护病房治疗的患者中风险更高。大多数脑卒中患者的结局较差。缺血性脑卒中与肺栓塞之间的关联需要进一步研究。